Highlights
• The study used Q-methodology to convert qualitative stakeholder insights into measurable patient preference profiles for female chronic pelvic pain (FCPP).
• Five distinct viewpoints emerged: Self-empowered Realist, Fearless Escalator, Careful Scientist, Trusting Optimist, and Eager to Move On.
• These profiles may help clinicians better tailor counseling and treatment selection to patient priorities, potentially improving engagement and adherence.
• The work is an important step toward patient-centered decision support, but it remains exploratory and requires validation in larger and more diverse cohorts.
Clinical Background / Unmet Need
Female chronic pelvic pain is a common, complex, and often disabling condition with multifactorial causes that may include gynecologic, urologic, gastrointestinal, musculoskeletal, neuropathic, and central sensitization mechanisms. Despite a wide range of available therapies, including medications, pelvic floor physical therapy, procedural interventions, and surgery in select cases, outcomes are frequently suboptimal. Many patients cycle through treatments without sustained relief, and adherence is often limited by prior negative experiences, side-effect concerns, lack of trust, cost, time burden, and misalignment between what clinicians recommend and what patients feel is acceptable.
A major challenge in FCPP care is that treatment success depends not only on biological efficacy but also on whether the chosen therapy fits the patient’s beliefs, goals, tolerance for uncertainty, and willingness to pursue stepwise escalation. Conventional clinical encounters may not adequately capture these preferences. As a result, shared decision-making is often incomplete, even though it is particularly important in pain syndromes where multiple reasonable treatment paths exist and no single option is uniformly effective.
Study Design
This study by Meriwether KV, Constantine M, Jiwani A, Misquez-Solis C, Ferraro E, and Brakey HR used Q-methodology, a structured approach designed to identify shared subjectivity and distinct patterns of viewpoint within a population. The investigators first drew on previously collected qualitative stakeholder data related to FCPP treatment choice. A patient advisory group (PAG) then helped interpret those data and refine a set of statements, or Q-set, in both English and Spanish.
Patients with FCPP completed Q-sorts, in which they ranked the statements according to how closely each statement matched their own perspective. The resulting sort patterns were analyzed using factor analysis to identify clusters of similar viewpoints. PAG members again contributed to interpreting the factors and assigning clinically meaningful labels. The study included 11 PAG members and 47 patients who completed the Q-sort.
The primary output was not a treatment efficacy comparison but a set of patient preference profiles intended to support future counseling tools and treatment-navigation instruments. The authors also explored preliminary links between each preference profile and treatment approaches that might be more acceptable to patients with similar viewpoints.
Key Findings
The analysis identified five distinct patient preference profiles. Each profile reflects a different way of thinking about pain, treatment burden, uncertainty, and the path toward improvement.
The Self-empowered Realist appears to value autonomy and pragmatism. This viewpoint likely reflects patients who want to be active participants in their care, recognize that chronic pelvic pain may not have a quick fix, and are willing to consider treatments that fit into a realistic long-term strategy. In counseling, these patients may respond well to clear explanations, actionable options, and respect for their own judgment.
The Fearless Escalator likely represents patients who are willing to advance through increasingly intensive treatments if earlier options fail. This profile suggests openness to escalation and possibly a lower threshold for trying more aggressive interventions when needed. Such patients may value a structured plan that makes the next step explicit if the current step is insufficient.
The Careful Scientist profile suggests a strong preference for evidence, predictability, and careful evaluation before committing to treatment. Patients aligned with this viewpoint may want detailed information about mechanisms, expected benefit, adverse effects, and the strength of supporting data. This group may be especially sensitive to uncertainty and may prefer therapies with a clear rationale and measurable outcomes.
The Trusting Optimist likely represents patients who have confidence in their clinicians and are willing to proceed with recommended therapies even when the evidence is imperfect. These individuals may prioritize a strong therapeutic alliance and reassurance from trusted providers. For them, clinician communication and trust may be as important as the treatment itself.
The Eager to Move On profile likely captures patients whose main goal is to end the burden of chronic pelvic pain and regain normal functioning as quickly as possible. Such patients may prioritize speed, convenience, and practical relief, potentially favoring options that promise an efficient path forward and minimizing prolonged trial-and-error treatment.
Importantly, the study did not suggest that any one profile is “best.” Rather, it demonstrated that patients with FCPP are not a homogeneous group. Different patients may endorse different combinations of viewpoints, and those viewpoints may influence which therapies they are willing to start, continue, or discontinue. The authors propose that these profiles could be mapped to treatment counseling, helping clinicians anticipate how a patient might respond to discussions about pelvic floor therapy, medications, procedures, or other interventions.
Clinical Interpretation and Expert Commentary
This study is notable because it moves beyond the traditional framing of chronic pelvic pain as a purely symptom-based condition. By translating qualitative experiences into measurable preference profiles, the investigators created a framework for understanding treatment choice as a patient-centered process. That is clinically relevant in a syndrome where therapeutic failure often reflects more than lack of pharmacologic efficacy.
The use of Q-methodology is particularly appropriate for conditions in which patient values are heterogeneous and difficult to reduce to simple survey scores. Unlike standard quantitative preference measures, Q-methodology is designed to surface shared subjectivities and distinguish clusters of opinion. In this context, it offers a practical bridge between narrative data and implementable clinical tools.
However, several limitations should be emphasized. First, the sample size was modest, with only 47 patients completing the Q-sort, so the factor structure should be considered hypothesis-generating rather than definitive. Second, the study was conducted with meaningful patient advisory input, but the resulting profiles still need external validation in larger, more diverse populations, including broader representation by race, ethnicity, language, geography, insurance status, and pain etiology. Third, while the authors preliminarily mapped profiles to treatment types, this mapping was not tested against actual treatment adherence, patient-reported outcomes, or comparative effectiveness. Finally, chronic pelvic pain is often comorbid with endometriosis, pelvic floor dysfunction, bladder pain syndrome, irritable bowel syndrome, and mood disorders, which may influence preferences in ways not fully captured by the current framework.
Even with these caveats, the study aligns with broader guideline and policy trends emphasizing shared decision-making, patient-reported outcomes, and individualized care. In a field where many therapies are reasonable but none uniformly effective, knowing how a patient approaches uncertainty, escalation, and trust may improve counseling quality and reduce mismatch between treatment plan and patient readiness.
Practical Implications
If validated, these preference profiles could support a more nuanced clinical conversation. For example, a Careful Scientist may benefit from evidence tables and explicit discussion of uncertainty, while a Trusting Optimist may prefer concise guidance anchored in clinician expertise. A Fearless Escalator might need a clear contingency pathway, whereas an Eager to Move On patient may value rapid-access interventions and concrete milestones.
In practice, such a framework could complement rather than replace standard history-taking. Clinicians could use a brief preference assessment to anticipate barriers to adherence, improve expectation setting, and individualize sequencing of therapies. This may be especially useful in multidisciplinary pelvic pain clinics, where treatment often involves coordination among gynecology, physical therapy, pain management, behavioral health, and sometimes urology or gastroenterology.
Conclusion
Meriwether and colleagues provide an important patient-centered contribution to chronic pelvic pain care by translating lived experience into five measurable treatment preference profiles. The work suggests that better treatment selection may depend not only on what is medically possible, but also on what is psychologically and practically acceptable to the patient. Although preliminary, these profiles offer a promising foundation for future decision-support tools, validation studies, and more personalized counseling in female chronic pelvic pain.
Funding and ClinicalTrials.gov
Funding information was not specified in the PubMed abstract. ClinicalTrials.gov registration was not reported.
References
1. Meriwether KV, Constantine M, Jiwani A, Misquez-Solis C, Ferraro E, Brakey HR. Translation of Chronic Pelvic Pain Experience into Patient Treatment Preference Profiles with Q-Methodology. Am J Obstet Gynecol. 2026 Jun 11. PMID: 42276499.
2. WHO. Patient engagement and shared decision-making resources in people-centered care. Relevant policy frameworks support incorporating patient preferences into treatment planning.
3. International guidance on chronic pelvic pain and endometriosis consistently emphasizes individualized management, multidisciplinary care, and shared decision-making in symptom-driven conditions.